Status:
COMPLETED
Vitamin D Supplementation on Cardiovascular Risk Factors
Lead Sponsor:
Florida International University
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
The purpose of the present pilot study is to determine the effect of vitamin D supplementation (4000 IU or 6000 IU once daily for 6 months) on reducing heart disease risk and in improving blood glucos...
Detailed Description
Insufficient vitamin D levels have been found in subjects with type 2 diabetes (T2D). Similarly, a negative association between serum vitamin D levels and insulin resistance has been reported in a lar...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- African American or Hispanic
- able to ambulate on their own
- aged between 30 - 70 years
Exclusion
- Taking Supplemental Vitamin D
- Pregnant or Lactating women
- Receiving insulin therapy
- Not participating in other drug trials
- HIV/ hepatitis/ cancer/ liver disease/ heart failure/ any recent surgery/ mental illness/ epilepsy/ any GI or malabsorption disorders
- Kidney failure or on dialysis
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT01412710
Start Date
July 1 2011
End Date
September 1 2013
Last Update
December 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Human Nutrition Laboratory, Florida International University
Miami, Florida, United States, 33199